Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road
Myron M. Levine(University of Maryland, Baltimore), Marcelo B. Sztein(University of Maryland, Baltimore), Eileen M. Barry(University of Maryland, Baltimore), Karen L. Kotloff(University of Maryland, Baltimore), Marcela F. Pasetti(University of Maryland Global Campus)
Cited by 372
Related Papers
Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet Infectious Diseases|2017|1.4k
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
|PubMed|1999|1.3k
Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study
|The Lancet|2019|923